FDA warns telaprevir can cause fatal rash
Patients taking telaprevir for hepatitis C are at risk of developing a serious skin rash that could be
fatal, the Food and Drug Administration has warned.
Source: Modern Medicine - Category: Journals (General) Source Type: news
More News: Food and Drug Administration (FDA) | General Medicine | Hepatitis | Hepatitis C | Incivek | Skin